MiR-9 mimic attenuated clinical symptoms associated with AD (Figure 4B) and exerted negative effects on the increased CXCL13 levels, amount of histamine released and serum prostaglandin E2 (Figure 4C). The gene discussed is CXCL13; the disease is Alzheimer disease.